Analyst Ratings for Intellia Therapeutics (NTLA) [Buys]

NTLA Rating Summary

NTLA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NTLA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $140.63 (-10.6%) * Over Last 12-Mos
Rating Score: 8.4 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/11/2021 H.C. Wainwright
» Updated 6/28/2021
Michael G. King, Jr. New Coverage Buy
(N/A)
171.00
(111.00)
83.15
(157.29)
89.16% Details
5/7/2021 Roth Capital
» Updated 8/5/2021
Tony Butler Upgrade Buy
(Neutral)
180.00
(110.00)
71.36
(157.29)
120.42% Details
Like NTLA Ratings? Also take a look at REGN, CRSP, BX, NIO

NTLA Ratings News